medigraphic.com
Instituto Nacional de Salud Pública

2008, Number 3

<< Back Next >>

salud publica mex 2008; 50 (3)

Expanded newborn screening using tandem mass spectrometry: Two years’ experience in Nuevo León, Mexico

Torres-Sepúlveda MR, Martínez-de Villarreal LE, Esmer C, González-Alanís R, Ruiz-Herrera C, Sánchez-Peña A, Mendoza-Cruz JA, Villarreal-Pérez JZ

Language: Spanish
References: 22
Page: 200-206
PDF size: 157.93 Kb.


ABSTRACT

Objective. To initiate a statewide expanded metabolic screening program in neonates with the purpose of identifying the most common inborn errors of metabolism. Material and Methods. From March 2002 through February 2004, a blood sample was obtained between 24 and 48 hours after delivery from every consecutive child born in public hospitals in Nuevo León. It was spotted on filter paper and analyzed by tandem mass spectrometry for expanded metabolic screening. Results. A total of 42 264 samples were analyzed. Were obtained seven positive results, one for each disorder: homocystinuria, hyperphenylalaninemia, citrulinemia, transient tyrosinemia, 3-methylcrotonyl CoA carboxylase deficiency, 3-hydroxy-3-methylglutaryl CoA deficiency, and classic galactosemia. Conclusions. The estimated incidence of inborn errors of metabolism is 1:5 000, with a false positive rate of 0.22%. The program permitted the identification of metabolic disorders in the newborn, allowing an early intervention and prevention of life-threatening events and permanent neurological damage.


REFERENCES

  1. MacCready RA, Hussey MG. Newborn phenylketonuria detection program in Massachusetts. Am J Pub Health 1964;54:2075-2081.

  2. Guthrie R, Susi A. A simple phenyalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338-343.

  3. Wilson JMG, Jungner F. Principles and practice of screening for disease. Public Health Papers. Geneva: Switzerland: World Health Organization, 1968:34.

  4. Guthrie R. Screening “Inborn errors of metabolism” in the newborn infant-a multiple test program. JAMA 1968;4:92-98.

  5. Sweetman L. Newborn screening by tandem mass spectrometry (MS/MS). Clin Chem 1996;42:345-346.

  6. Millington DS, Norwood DL, Kodo N. Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood and tissue. Anal Biochem 1989;180:331-339.

  7. Rashed MS, Ozand PT, Bucknall DN. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995;38:324-331.

  8. Hunt DF, Giordani ABB, Rhodes G, Herold DA. Mixture analysis by triple quadrupole mass spectrometry: metabolic profiling of urinary carboxylic acids. Clin Chem 1982;28:2387-2392.

  9. Chace DH, Kalas TA. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin Biochem 2005;38:296-309.

  10. Chace D. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 2003;49(11):1797-1817.

  11. Willey V, Carpenter K, Wilcken B. Newborn screening with tandem mass spectrometry: 12 months´ experience in NSW Australia. Acta Paediatr 1999;(suppl 88):48-51.

  12. Simonsen H, Jensen UG. Technical aspects of neonatal screening using tandem mass spectrometry. Report for 4th Meeting of the International Society for Neonatal Screening. Acta Paediatr 1999;432:52-54.

  13. Velázquez A, Loera A, Aguirre BE, Gamboa S, Vargas H, Robles C. Tamiz neonatal para hipotiroidismo congénito y fenilcetonuria. Salud Publica Mex 1994;36:249-256.

  14. Ibarra I, Fernández C, Belmont L, Vela M. Elevada mortalidad y discapacidad en niños mexicanos con enfermedad de orina de jarabe de arce (EOJA). Gac Med Mex 2007;143(3):197-201.

  15. Norma Oficial Mexicana NOM-034-SSA2-2002. Para la prevención y control de los defectos al nacimiento. Diario Oficial de la Federación, México DF, lunes 23 de octubre de 2003.

  16. Millington D, Koeberl D. Metabolic screening in the newborn. GGH 2003;19(3):33-38.

  17. Chace DH, Sherwin JE, Hillman S, Lorey F, Cunningham GC. Use of phenylalanine to tirosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours. Clin Chem 1998;44:2405-2409.

  18. Sweetman L. Newborn screening by tandem mass spectrometry: gaining experience. Clin Chem 2001;47:1937-1938.

  19. Kaye CI. Introduction to the newborn screening. Fact Sheets. Pediatrics 2006;118:1304-1312.

  20. Rashed M. Clinical applications of tandem mass spectrometry: ten years of diagnosis and screening for inherited metabolic diseases. J Chromatogr B 2001;758:27-48.

  21. Webster D, Dhondt JL, Hannon WH, Loeber G, Torresani T. Quality assurance and standardization: summary of the satellite meeting, Turku, Finland. Acta Paediatr 1999;(suppl 88):7-12.

  22. Chace DH. Mass spectrometry in the clinical laboratory. Chem Rev 2001;101:445-477.




2020     |     www.medigraphic.com